Viking Global Investors
EW icon

Viking Global Investors’s Edwards Lifesciences EW Stock Holding History

Viking Global Investors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.9M Buy
+1,097,578
New +$90.5M 0.25% 67
2025
Q4 		– Sell
-3,069,151
Closed -$239M – 87
2025
Q3 		$239M Buy
+3,069,151
New +$240M 0.62% 50
2020
Q1 		– Sell
-475,719
Closed -$37M – 71
2019
Q4 		$37M Sell
475,719
-136,725
-22% -$10.7M 0.17% 59
2019
Q3 		$44.9M Buy
+612,444
New +$43M 0.23% 48

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Viking Global Investors's EW Position: Q1 2026 in Review

Viking Global Investors opened a new position in Edwards Lifesciences (EW) in Q1 2026: 1,097,578 shares worth $87.9M. The stake represents 0.25% of the portfolio and ranks #67 among its holdings. This is a return to the name: Viking Global Investors previously reported a position in EW as recently as Q3 2025.

Viking Global Investors first reported a position in EW in Q3 2019 and has held it in 4 quarters since. The position peaked at $239M in Q3 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Viking Global Investors held 1,097,578 shares of Edwards Lifesciences worth $87.9M as of Q1 2026.
  • Edwards Lifesciences was a new Viking Global Investors position in Q1 2026.
  • Edwards Lifesciences made up 0.25% of Viking Global Investors's portfolio in Q1 2026, its #67 holding.
  • Viking Global Investors first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 4 quarters since.
  • Viking Global Investors's Edwards Lifesciences position peaked at $239M in Q3 2025.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Viking Global Investors's 13F filing for Q1 2026, filed 15 May 2026.